AI-curated news about real-world psychedelic research, policy, and developments
Newly funded studies explore how our Perception Box is formed, what causes it to narrow or expand, and whether experiences, including mindfulness, dreams, psychedelics, play, and virtual reality, can help us become more aware of what shapes our experience and…
Key appointment strengthens operational leadership as Psilera prepares its lead neuroplastogen, PSIL-006, for clinical-stage evaluation. TAMPA, Fla., Aug. 27, 2026 /PRNewswire/ -- Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-g…
NEW YORK — Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, t…
Caught red-handed!ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
Melvin Benn also said he has no plans to lift the festival’s ban on teenagers or reveal future line-ups before tickets go on sale.
Over the past several months, I’ve been building Ketalux.com, an independent educational platform focused on ketamine therapy, research, safety, treatment options, clinical trials, regulation, providers, and the rapidly evolving ecosystem surrounding ketamine…
A new, small study of a one-time treatment showed that all patients reached remission of postpartum depression by day 1.
What ensued was a wild night of crazed celebrations, alleged drink and drug-fueled debauchery and alleged sexcapades that spiraled into the most sordid sports scandal in a generation.
Researchers are exploring whether magic mushrooms could offer a new treatment for anorexia
For those living in the shadow of mental health conditions such as PTSD, anxiety, and depression, finding a way forward can sometimes feel impossible – especially when conventional treatments have offered little succor.
“Our psychedelic-climate leaders are active today, creating change and doing compelling transformational work in this space.” The post Psychedelics for Climate Action (12,000 cultists) appeared first on Watts Up With That?.
A feasibility trial delivering psilocybin-assisted therapy for treatment-resistant depression within the UK health service reports encouraging adherence and safety — it opens future questions about who is reached, where treatment happens and what standards wi…
Psychedelics are becoming more clinically relevant, and a slew of recent research has explored the effects of psilocybin in ever-greater detail, revealing that it has the ability to imprint lasting, meaningful changes in brain activity. Psilocybin, the psych…
Rogan had called the President's attention to psychedelics by texting him a message with statistics about how ibogaine could help reduce opioid addiction.
DNA sequencing linked identical visions of tiny people in China and the Philippines to a single mushroom that contains no known hallucinogens.
Brains scans show a signature linked to a dissolved separation between the self and the world.
VCU chemists rebuilt the psychedelic quipazine to hit the brain receptor tied to antidepressant effects while skipping the gut receptor behind nausea.
Oregon was the first state to establish a legalized and regulated psilocybin industry. Since then, thousands have tried magic mushrooms. Here is the first data from the state's real life experiment.
Psychedelics are inherently chaotic drugs, dissolving the boundary between self and surrounds by sowing discord in the brain.Continue ReadingCategory: Mental Health, Brain Health, Body and Mind, Refractor: Science & HealthTags: Psychedelic Medicine, psilocybi…
The psychedelic psilocybin reorganizes brain activity into structured, context-aligned patterns that integrate internal and external processing, providing a neural basis for the felt continuity between self and world, elucidating how the psychedelic stat…
The University of Miami has given its investigational new drug application of ibogaine, a plant-based psychoactive compound, to the federal government, President Donald Trump said Tuesday. The post Trump: University of Miami Gives Ibogaine Investigational Dr…
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) — Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “…
Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization Ms. Donohue is the former Chief Human Re…
Ibogaine joins a growing list of psychedelic drugs that have been found to potentially have beneficial effects on brain health and mood.
VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it…
Definium says a single dose of its LSD tablet cut anxiety scores by 5.4 points more than placebo at 12 weeks in a 214-person Phase 3 trial.
The U.S. Department of Veterans Affairs today announced the launch of a new clinical trial to evaluate the effectiveness and safety of psilocybin to treat major depression in Veterans, including those with concurrent PTSD.The new trial comes after a recent ex…
On The Political Scene Podcast, Trump’s executive order accelerating research into compounds like ibogaine marks a striking turn for a party that was once on the front lines of the war on drugs.
Definium Therapeutics (DFTX) unveiled the second positive Phase 3 study for its LSD-based drug on Thursday, and the biotech stock jumped. Patients with generalized anxiety disorder, or GAD, showed a 5.4-point improvement compared with a placebo on the 56-poin…
Definium Therapeutics unveiled the second of two positive Phase 3 studies for its LSD-based drug. The biotech stock surged on the results. The post This LSD-Based Drug Just Scored Again. Definium Stock Soars. appeared first on Investor's Business Daily.
Collaboration will leverage Osmind's real-world evidence platform and national clinical network to support Tasman's pivotal Phase 3 ROCKET program, launch readiness, and growth. R-107 is an investigational oral extended-release ketamine product designed for a…
Study met primary and all key secondary efficacy endpoints Participants receiving DT120 ODT achieved a statistically significant reduction in Hamilton Anxiety Rating Scale (HAM-A) score, with a placebo-adjusted change of 5.4 points from baseline at Week 12 (p
It was to be the holiday of my dreams - a solo trip to Japan, a destination that had long been high on my wish list.
In 2026, roughly one in eight American adults is on a GLP-1 like Ozempic, Wegovy, or Mounjaro, more than double the rate of eighteen months earlier. They were originally developed to treat type 2 diabetes; Ozempic won FDA approval for that in 2017, well befor…
A researcher speaks about the Lilliputian mushroom, the decades-long mystery behind it, and the implications of a new hallucinogenic compound.
For nearly a century, scientists have been baffled by bizarre reports of hallucinations that leave people seeing dozens or even hundreds of tiny human figures.
As psychedelic therapies expand, new clinics treat uncommon long-term harms
“We didn’t expect to see this."ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) — Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceut…
Willy Myco has made over 120 videos showing people his exact process for making everything from LSD to DMT vapes. Not everyone’s a fan of his methods.
Psychedelic-assisted therapy could open a new path for treating cocaine use disorder, which has no approved medications yet
The mother of one patient said she had even wondered whether to start planning her daughter's funeral.
An open library of psychedelic, meditation, dream, and consciousness research. Plain-language summaries with study design and sample size, free to read.
The so-called God Molecule has an egomaniacal prophet.
The Department of Veterans Affairs (VA) has launched a new medical trial to determine the effectiveness of using psilocybin to treat depression in veterans. In April, President Donald Trump issued an executive order to expand access to and trials of psychedel…
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) today announced that the FDA has completed first-cycle review of the Company’s ANDA for its preservative-free ketamine, with no major deficiencies related to the drug product, i…
How the conservative activist Bryan Hubbard, with help from Rick Perry and Joe Rogan, persuaded Trump and the G.O.P. to embrace ibogaine, a psychedelic drug derived from an African shrub. Michelle Lhooq writes.
As Alaska and the rest of the nation search for innovative solutions to combat rising mental health crises, a Massachusetts law enforcement leader says the key to saving lives lies in transforming how first responders approach human suffering.
Better U outlines its telehealth platform, clinician evaluation, peer-support monitoring and financing terms for at-home ketamine care....
Arizona granted Barrow Neurological Institute $5 million for an ibogaine trial in traumatic brain injury. The design, the Schedule I status, and the cardiac risk.
